BFS
LEGN icon

Bare Financial Services’s Legend Biotech LEGN Stock Holding History

Bare Financial Services’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13K Hold
39
– – ﹤0.01% 1330
2026
Q1 		$706 Buy
+39
New +$743 ﹤0.01% 1378

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Bare Financial Services's LEGN Position: Q2 2026 in Review

Bare Financial Services held its Legend Biotech (LEGN) position steady in Q2 2026 at 39 shares worth $1.13K. The position accounts for ﹤0.01% of the portfolio, ranked #1330.

Bare Financial Services first reported a position in LEGN in Q1 2026 and has held it in 2 quarters since. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Bare Financial Services held 39 shares of Legend Biotech worth $1.13K as of Q2 2026.
  • Bare Financial Services left its Legend Biotech share count unchanged in Q2 2026.
  • Legend Biotech made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #1330 holding.
  • Bare Financial Services first reported a position in Legend Biotech in Q1 2026 and has held it in 2 quarters since.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.